Data / Drug companies / Oxymorphone hydrochloride
Oxymorphone hydrochloride: 9 companies and 27 products in the FDA NDC directory
Oxymorphone hydrochloride is listed in the FDA National Drug Code Directory by 9 companies, with 27 products in commercial distribution. 27 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated, extended release; tablet, and the newest product started marketing on May 6, 2020.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 9
- Products
- 27
- Generic (ANDA) products
- 27 (100.0%)
- Application numbers
- 6
- Controlled substance schedule
- Schedule II
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list oxymorphone hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | 7 | tablet, film coated, extended release | Generic drugs (ANDA) | January 2, 2013 |
| Amneal Pharmaceuticals of New York LLC | 7 | tablet, film coated, extended release | Generic drugs (ANDA) | January 2, 2013 |
| Aurolife Pharma, LLC | 2 | tablet | Generic drugs (ANDA) | April 26, 2016 |
| Camber Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | March 1, 2018 |
| Epic Pharma, LLC | 2 | tablet | Generic drugs (ANDA) | May 15, 2019 |
| Hikma Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | September 27, 2010 |
| KVK-Tech, Inc. | 2 | tablet | Generic drugs (ANDA) | February 11, 2013 |
| XLCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | May 6, 2020 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | March 1, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated, extended release | 14 | 51.9% |
| Tablet | 13 | 48.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 27 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Opioid Agonist | 27 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.